PAR 12.7% 31.0¢ paradigm biopharmaceuticals limited..

Ann: Quarterly Update and Appendix 4C - quarterly, page-47

  1. 9,704 Posts.
    lightbulb Created with Sketch. 1234
    A reminder that shorts will also buy back on market, and once in possession of the new stock can then reload the sell side. End of session appeared to be a rinse and repeat, which may mean they're having to go harder to get the required volume to reduce their net short exposure. I'm expecting more games into end of Sept (OA_008) as they get more desperate to reduce exposure.




 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.